Medical

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today that Interim Analysis of an on-going Phase I/II study of Rexin-G for pancreatic cancer confirmed Rexin-G's anti-tumor activity with no major toxicity in patients with metastatic chemotherapy-resistant pancreatic cancer. The clinical trial design includes 5 escalating doses of intravenous Rexin-G.

STAMFORD, Conn. -- Approximately 80 percent of Americans suffer from low back pain. Second to the common cold, low back pain is the number one reason for a visit to a primary care doctor. And it is the fifth most frequent cause of hospitalization. Dr. Scott Bender, D.C., of the Connecticut Spine & Health Center in Stamford, Connecticut, offers hope for those who suffer from the agonizing, oft-times debilitating pain of low back ailments.

MOUNT VERNON, Wash. -- PreViser Corporation, a Washington State-based provider of patented oral disease and risk assessment software technology to the dental industry, announced today the finalization of a licensing agreement with White Cross GmbH of Lindau, Germany, to market PreViser technology to dentists within Germany, Austria and portions of Switzerland.

SUNRISE, Fla. -- Interim HealthCare, one of the nation's largest home care and health care staffing companies, proudly recognizes the important role Social Workers play in home care, hospice and hospitals throughout the year and during National Social Work Month.

HEATHSVILLE, Va. -- Safe Return! Wilderness Emergency Care & Survival Training Center, an independent American Safety and Health Institute authorized training center, is offering schools, groups, and organizations with outdoor and public safety interests free medical emergency care seminars as an outreach and public information service.

STERLING HEIGHTS, Mich. -- With Valentine's Day just around the corner, Dr. Mark Berkowitz, Medical Director of Accents Cosmetic Surgery and Medical Spa, is just in time to prepare pouty lips and transform thin lips for a special Valentine's Day. Berkowitz has just released a free, fact-filled report, entitled: "Lip Tips You'll Love."

DETROIT, Mich. -- Though we were all born with smooth, baby-soft skin the effects of time and heredity begin to show on the faces of Detroiter's of all ages. Dr. Mark Berkowitz of Accents Cosmetic Surgery and Medical Spa has reintroduced many people to more vibrant, youthful, and healthy-looking skin with a single, 30-minute in-office treatment using the newest fractional laser technology imported just last month from Italy.

ENCINO, Calif. -- In December 2007, MedSort.com, a premier online personal medication list management system, launched a comprehensive personal health records system - MedSort Health(TM) - which empowers consumers and patients to take control of their health records.

DETROIT, Mich. -- While Dr. Mark Berkowitz's patients complain frequently about drooping eyelids, sagging skin, and deep wrinkles, these days their main concerns are how to avoid surgery, anesthesia, lengthy recovery time, and hefty surgical fees. To satisfy his patients, Berkowitz and his Accents Cosmetic Surgery and Medical Spa now has a cache of non-surgical services to address this wildly growing trend.

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today that the company has received a Certificate of Product Registration for Rexin-G(R) from the Philippine Bureau of Food and Drugs (BFAD), enabling the commercialization of its lead product as a safe and effective treatment for a broad spectrum of intractable cancers.

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today that the company has taken a major step toward the commercialization of its lead product with the opening of a Phase II Registration Protocol using Rexin-G for osteosarcoma in the United States. Following the accelerated approval of Rexin-G for the treatment of all solid tumors by the Bureau of Food and Drugs in the Philippines, Epeius opened a number of Phase I/II clinical trials.

SAN MARINO, Calif. and BOSTON, Mass. -- Epeius Biotechnologies Corporation today announced that Dr. Frederick L. Hall, President and CEO of Epeius Biotechnologies Inc., has accepted an invitation to give the lead keynote address on "The Advent of Pathotropic Medicine for Cancer" at the Global Pharma R&D Summit 2007 to be held in Boston MA. On October 22, 2007 at 8:00 a.m., Dr. Hall will present the scientific principles, the clinical validation, and global development status.

RICHMOND, Texas -- CYNACON / OCuSOFT (OCuSOFT, Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, is pleased to announce the appointment of Katherine Mastrota, M.S., O.D., to its Optometric Scientific Advisory Board.

MOUNT VERNON, Wash. -- PreViser Corporation, a world leader in risk and disease analysis software that enhances treatment planning for patients affected by oral disease, announced a simultaneous release of a new corporate website and a major upgrade to its software.

SAN FRANCISCO, Calif. -- California Kidney Cancer Foundation Executive Director, Dr. David Minor will present a review of treatments for metastatic kidney cancer as presented at the most recent American Society of Clinical Oncology Conference. The presentation will be from 3 to 5 PM on September 15, 2007 at California Pacific Medical Center.

RICHMOND, Texas -- CYNACON / OCuSOFT (OCuSOFT, Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, is pleased to announce the appointment of Edward J. Holland, M.D. to its Medical Scientific Advisory Board.

MACCLENNY, Fla. -- Baker County Medical Services which operates Ed Fraser Memorial Hospital in Macclenny, Florida announced today that they have posted all of their hospital charges contained in their Charge Master on their website.

RICHMOND, Texas -- CYNACON/OCuSOFT(R) (OCuSOFT, Inc.) specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They are excited to announce a new and innovative prescription-only ALODOX(R) Convenience Kit for adjunctive eyelid therapy and hygiene.

RICHMOND, Texas -- CYNACON / OCuSOFT (OCuSOFT, Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, today announced the appointment of Lawrence A. Yannuzzi, M.D. to its Medical Scientific Advisory Board.

DURHAM, N.C. -- Heart Imaging Technologies (HeartIT) announced today that medical images can be viewed on Apple's new iPhone. Physicians can simply click on a web link sent via email by one of their colleagues, enter their password, and, for example, instantly view movies of a patient's beating heart halfway around the world.

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today that an advanced Phase I/II clinical trial using intravenous Rexin-G(TM) for pancreatic cancer that is refractory to standard chemotherapy will open in the summer of 2007 in Los Angeles, California. Rexin-G is the world's first tumor-targeted injectable gene delivery system that is designed to seek out and destroy both primary tumors and metastatic cancers that have spread throughout the body.

CHARLOTTE, N.C. -- The National Children's Oral Health Foundation (NCOHF) and PreViser Corporation today announced a joint initiative to collaborate in an effort to improve the oral health of low income children nationwide. The NCOHF, whose non-profit mission is to eliminate oral disease, and promote overall health and well-being for economically disadvantaged children.

LONDON, UK -- Crescent Diagnostics Ltd ("Crescent"), today announced the publication of a recent study demonstrating the potential of the Bone Quality Test, BQT(TM) to diagnose osteoporosis. More women at risk can be screened with an accurate, simple to use test which does not require a hospital visit.

TEHACHAPI, Calif. -- The Tehachapi Hospital Foundation, an IRS 501(c)(3) organization, is actively seeking funds to build a new hospital in a region between Lancaster and Bakersfield, CA - Tehachapi. The present Tehachapi Hospital is unable to meet state-mandated earthquake safety requirements; the existing structure cannot be retrofitted.

STERLING HEIGHTS, Mich. -- "We no longer need to dream of the ideal treatment to correct sunken cheeks, hollow eye, deep indentations associated with facial fat loss brought on with age," explains Mark Berkowitz, a Detroit-area Cosmetic Surgeon. SCULPTRA(TM) is a safe, synthetic, and biocompatible cosmetic treatment.